Updated:
Aceras BioMedical
Aceras BioMedical is a private equity firm headquartered in New York, United States, with a website at acerasbio.com. It is a healthcare investment firm...
Aceras BioMedical
Aceras BioMedical is a private equity firm headquartered in New York, United States, with a website at acerasbio.com. It is a healthcare investment firm focused on emerging biotechnology and medical device companies. Aceras BioMedical specializes in licensing, acquisition, and internal development of therapeutic products and medical devices. The firm pursues these strategies through new company formations. It has made one investment, in Modis Therapeutics, as part of their Series A on October 01, 2018. Aceras BioMedical has also achieved one portfolio exit, Modis Therapeutics, on August 26, 2019.
General information
Firm type
Private Equity
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, United States
Sector focus
Frequently asked questions
What is Aceras BioMedical's investment focus?
Aceras BioMedical is a healthcare investment firm focused on emerging biotechnology and medical device companies. It specializes in licensing, acquisition, and internal development of therapeutic products and medical devices through new company formations.
What investment has Aceras BioMedical made?
Aceras BioMedical has made one investment in Modis Therapeutics as part of their Series A on October 01, 2018. The firm also had one portfolio exit with Modis Therapeutics on August 26, 2019.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: